Retrospective evaluation of multidisciplinary perioperative hemostatic management in oral surgery for patients with hemophilia
- 1Department of Oral and Maxillofacial Surgery, Busan Paik Hospital, Inje University Busan Korea
Abstract
Objectives: This study evaluated the clinical efficacy and safety of an individualized, multidisciplinary perioperative hemostatic management coordinated by the Department of Pediatrics for oral and maxillofacial surgery in hemophilia patients at a single tertiary medical center.
Materials and Methods: We retrospectively reviewed 13 hemophilia patients (hemophilia A: 11; hemophilia B: 2) who underwent oral surgery under individualized multidisciplinary perioperative hemostatic management at Busan Paik Hospital, Inje University, between 2021 and 2025, including preoperative hospital admission, individualized clotting factor replacement, intravenous tranexamic acid, and preoperative confirmation of activated partial thromboplastin time (aPTT). The primary outcome was intraoperative and postoperative hemorrhagic complications.
Results: A total of 21 surgical cases (including 37 tooth extractions) were analyzed. Disease severity was severe in 7 patients (58.3%), moderate in 2 (16.7%), and mild in 3 (25.0%); one patient with undocumented factor activity was excluded. One inhibitor-positive patient was managed with activated prothrombin complex concentrate (FEIBA). By World Federation of Hemophilia classification, 16 cases (76.2%) were major and 5 (23.8%) minor procedures. The primary hemostasis success rate was 95.2% (20/21 cases), and the overall complication rate was 14.3% (3/21 cases): one readmission for delayed secondary hemorrhage (mild hemophilia B), one odontogenic cellulitis, and one minor intraoperative oozing in the inhibitor-positive patient. Mean hospital stay was 5.5±1.5 days (inpatients only, n=16/21; range 4-9). No uncontrolled major hemorrhage or mortality occurred.
Conclusion: In this small single-center retrospective series without a control group, individualized multidisciplinary perioperative hemostatic management was associated with favorable outcomes (success rate 95.2%; complication rate 14.3%). These descriptive findings suggest that multidisciplinary collaboration, perioperative confirmation of inhibitor status, and thorough discharge education may be important components of perioperative care in hemophilia patients, though they should not be interpreted as demonstrating the causal superiority of any single care model, pending prospective, controlled confirmation.
Related
- Construction of a multidisciplinary perioperative nutritional management scheme for endoscopic therapy in patients with biliary tract malignancies
- A Multidisciplinary Neuro-Lupus Program for the Evaluation and Management of Patients With SLE and Cognitive Concerns
- Reply to Crespo, J.; Iruzubieta, P. Comment on "Orozco-Beltrán et al. Evaluation, Management and Therapeutic Approach of Cardiovascular-Kidney-Metabolic Syndrome: A Multidisciplinary Delphi Expert Consensus. J. Clin. Med. 2025, 14, 8930".
- Perinatal multidisciplinary management for neonates with prenatally-diagnosed congenital complete heart block undergoing early epicardial pacemaker implantation: a retrospective single-center case series
- Multidisciplinary Management of Neuroendocrine Neoplasms Beyond Centers of Excellence: Retrospective Real-World Data from a Referral Center in Eastern Europe
BibTeX
@article{jung2026retrospective,
title = {{Retrospective evaluation of multidisciplinary perioperative hemostatic management in oral surgery for patients with hemophilia}},
author = {Tae Young Jung},
journal = {Journal of the Korean Association of Oral and Maxillofacial Surgeons},
year = {2026},
month = oct,
doi = {10.5125/jkaoms.2026.52.5.219},
url = {https://doi.org/10.5125/jkaoms.2026.52.5.219},
note = {CC BY-NC 4.0},
}
RIS
TY - JOUR
TI - Retrospective evaluation of multidisciplinary perioperative hemostatic management in oral surgery for patients with hemophilia
AU - Tae Young Jung
PY - 2026
DA - 2026/10/31
JO - Journal of the Korean Association of Oral and Maxillofacial Surgeons
DO - 10.5125/jkaoms.2026.52.5.219
UR - https://doi.org/10.5125/jkaoms.2026.52.5.219
AB - Objectives: This study evaluated the clinical efficacy and safety of an individualized, multidisciplinary perioperative hemostatic management coordinated by the Department of Pediatrics for oral and maxillofacial surgery in hemophilia patients at a single tertiary medical center. Materials and Methods: We retrospectively reviewed 13 hemophilia patients (hemophilia A: 11; hemophilia B: 2) who underwent oral surgery under individualized multidisciplinary perioperative hemostatic management at Busan Paik Hospital, Inje University, between 2021 and 2025, including preoperative hospital admission, individualized clotting factor replacement, intravenous tranexamic acid, and preoperative confirmation of activated partial thromboplastin time (aPTT). The primary outcome was intraoperative and postoperative hemorrhagic complications. Results: A total of 21 surgical cases (including 37 tooth extractions) were analyzed. Disease severity was severe in 7 patients (58.3%), moderate in 2 (16.7%), and mild in 3 (25.0%); one patient with undocumented factor activity was excluded. One inhibitor-positive patient was managed with activated prothrombin complex concentrate (FEIBA). By World Federation of Hemophilia classification, 16 cases (76.2%) were major and 5 (23.8%) minor procedures. The primary hemostasis success rate was 95.2% (20/21 cases), and the overall complication rate was 14.3% (3/21 cases): one readmission for delayed secondary hemorrhage (mild hemophilia B), one odontogenic cellulitis, and one minor intraoperative oozing in the inhibitor-positive patient. Mean hospital stay was 5.5±1.5 days (inpatients only, n=16/21; range 4-9). No uncontrolled major hemorrhage or mortality occurred. Conclusion: In this small single-center retrospective series without a control group, individualized multidisciplinary perioperative hemostatic management was associated with favorable outcomes (success rate 95.2%; complication rate 14.3%). These descriptive findings suggest that multidisciplinary collaboration, perioperative confirmation of inhibitor status, and thorough discharge education may be important components of perioperative care in hemophilia patients, though they should not be interpreted as demonstrating the causal superiority of any single care model, pending prospective, controlled confirmation.
SN - 2234-7550
SN - 2234-5930
ER -